Table 4.
d-17 (3 d after challenge) | d-20 (6 d after challenge) | |||
---|---|---|---|---|
|
|
|||
NE lesion scores | C. perfringens counts (105 CFU/g) | NE lesion scores | C. perfringens counts (105 CFU/g) | |
FED | ||||
Control | 2.17a | 6.38a | 1.38a | 0.98a |
Antibiotic | 0.00c | 0.00b | 0.13bc | 0.00b |
MOS | 1.88a | 1.20ab | 0.75ab | 0.68ab |
Acidifier | 1.88a | 1.44ab | 0.75ab | 0.33ab |
HELD | ||||
Control | 2.00a | 1.24ab | 0.75ab | 0.03b |
Antibiotic | 0.25bc | 0.00b | 0.00c | 0.00b |
MOS | 1.63ab | 2.58ab | 1.75a | 1.10a |
Acidifier | 2.38a | 2.56ab | 1.00ab | 0.30ab |
SEM | 0.53 | 1.84 | 0.30 | 0.31 |
———Significance of treatment effect2——— | ||||
Diet | *** | NS | ** | NS |
Holding time | NS | NS | NS | NS |
Diet×holding time | NS | NS | NS | NS |
Values are means of 4 replicates for each treatment group.
NS = Not significant;
p<0.05;
p<0.01;
p<0.001.
Means within a column without a common superscript differ significantly.